| Evidence | Polymorphism in End-Stage Renal Disease
- Noiri E, Satoh H, Taguchi J, Brodsky SV, Nakao A, Ogawa Y, Nishijima S, Yokomizo T, Tokunaga K, Fujita T Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 2002 Oct;40(4):535-40.
- Wang Y, Kikuchi S, Suzuki H, Nagase S, Koyama A Endothelial nitric oxide synthase gene polymorphism in intron 4 affectsthe progression of renal failure in non-diabetic renal diseases. Nephrol Dial Transplant 1999 Dec;14(12):2898-902.
Polymorphism in Kidney Cystic Disease
- Persu A, Stoenoiu MS, Messiaen T, Davila S, Robino C, El-Khattabi O, Mourad M, Horie S, Feron O, Balligand JL, Wattiez R, Pirson Y, Chauveau D, Lens XM, Devuyst O Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 2002 Feb 1;11(3):229-41.
Polymorphism in Nephrotic Syndrome
- Asakimori Y, Yorioka N, Yamamoto I, Okumoto S, Doi S, Hirai T, Taniguchi Y Endothelial nitric oxide synthase intron 4 polymorphism influences theprogression of renal disease. Nephron 2001 Oct;89(2):219-23.
- Morita T, Ito H, Suehiro T, Tahara K, Matsumori A, Chikazawa H, Nakauchi Y, Nishiya K, Hashimoto K Effect of a polymorphism of endothelial nitric oxide synthase gene inJapanese patients with IgA nephropathy. Clin Nephrol 1999 Oct;52(4):203-9.
Other key publications related to this gene
|
